Consider Eurofins DiscoverX’s custom development capabilities for custom cell lines, assays, & enzyme development.
PROTAC® is a registered trademark of Arvinas.
Ubiquitination is a highly orchestrated post-translational modification where the ubiquitin polypeptide is covalently conjugated to target proteins through an enzyme-dependent cascade. This multilayered and dynamically regulated process governs a wide spectrum of cellular activities, including proteasomal degradation, cell-cycle progression, DNA damage recognition, and repair. Ubiquitination also functions as a central component of the protein quality-control machinery, ensuring the removal of misfolded or damaged proteins. Perturbations in ubiquitin pathway homeostasis are strongly associated with the pathogenesis of multiple disorders, notably cancer and neurodegenerative diseases. As a result, components of the ubiquitination cascade have emerged as compelling targets for therapeutic intervention and drug development.
Eurofins DiscoverX provides a wide range of recombinant proteins designed to facilitate research programs that explore ubiquitination. These validated recombinant ubiquitination cascade components, including functionally active E1, E2, and E3 enzymes, allow you to study and manipulate the ubiquitin system in vitro with high confidence and reproducibility.
Partner with us to bring high-quality, pre-clinical–ready ubiquitination biochemistry into your laboratory and accelerate your path from discovery to therapeutic development.
Consider Eurofins DiscoverX’s custom development capabilities for custom cell lines, assays, & enzyme development.
PROTAC® is a registered trademark of Arvinas.